跳转到主内容

非常抱歉,我们不完全支持您的浏览器。如果您可以选择,请升级到较新版本或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更高版本。如果您无法进行此操作且需要支持,请将您的反馈发送给我们。

全新设计的官网为您带来全新体验,期待您的反馈在新的选项卡/窗口中打开

Elsevier
通过我们出版

Amadea Britton

AB

Amadea Britton

CDC/NCIRD, USA

Preliminary Talk Title: U.S. Experience with Respiratory Syncytial Virus (RSV) Prevention Product Introduction

Dr. Amadea Britton currently serves as a Medical Officer at the U.S. Centers for Disease Control and Prevention (CDC) where she works on the Vaccine Effectiveness and Policy Team in the Coronavirus and Other Respiratory Viruses Division. She is the Co-Lead of the U.S. Advisory Committee on Immunization Practices (ACIP) Work Group for RSV Vaccines in Adults and has contributed extensively to U.S. RSV vaccine policy development. Dr. Britton is a board-certified physician and completed Internal Medicine/Pediatrics clinical training at Duke University. She also holds a Master of Science from the Harvard T.H. Chan School of Public Health and is a former CDC Epidemic Intelligence Service Officer.